Almada, Portugal Clinical Trials

Anemia

Site PT35120

A clinical research study of roxadustat, epoetin alfa and darbepoetin alfa for the treatment of Anemia or End Stage Renal Disease (ESRD)

Site PT35120

A clinical trial seeking patients for a research study for the treatment of Anemia in Chronic Kidney Disease in Non-dialysis Patients

Atrial Fibrillation

1160.136.17005 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

1160.186.35105 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation or Percutaneous Coronary Intervention

Diabetes Mellitus, Type 2

Research Site

A clinical trial to evaluate treatments using semaglutide and Dulaglutide for patients with Diabetes or Diabetes Mellitus, Type 2

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Diabetic Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Heart Failure

Novartis Investigative Site

A clinical research study of the Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) Patients

Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Site PT35120

A clinical trial seeking patients for a research study for the treatment of Anemia in Chronic Kidney Disease in Non-dialysis Patients

Site PT35120

A clinical research study of roxadustat, epoetin alfa and darbepoetin alfa for the treatment of Anemia or End Stage Renal Disease (ESRD)

Site Reference ID/Investigator# 141333

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Neoplasm Metastasis

1160.189.35203 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Nephropathy

Site Reference ID/Investigator# 141333

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Stroke

Research Site

A clinical trial to evaluate treatments using Rivaroxaban (Xarelto, BAY59-7939), Aspirin (Acetylsalicylic acid, BAY1019036), Rivaroxaban-Placebo and Aspirin-Placebo for patients with Stroke

1160.136.17005 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

1160.189.35203 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Investigator Site

A clinical trial seeking patients for a research study for the treatment of Systemic Lupus Erythematosus

Thromboembolism

Research Site

A clinical trial to evaluate treatments using Rivaroxaban (Xarelto, BAY59-7939), Aspirin (Acetylsalicylic acid, BAY1019036), Rivaroxaban-Placebo and Aspirin-Placebo for patients with Stroke

Ulcerative Colitis

Research Site

Patients are needed to participate in a clinical research study evaluating etrolizumab, infliximab, placebo (IV) and placebo (injection) for the treatment of Ulcerative Colitis

Ulcers

Research Site

Patients are needed to participate in a clinical research study evaluating etrolizumab, infliximab, placebo (IV) and placebo (injection) for the treatment of Ulcerative Colitis